1. Home
  2. TNGX vs OBT Comparison

TNGX vs OBT Comparison

Compare TNGX & OBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • OBT
  • Stock Information
  • Founded
  • TNGX 2014
  • OBT 1892
  • Country
  • TNGX United States
  • OBT United States
  • Employees
  • TNGX N/A
  • OBT N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • OBT Major Banks
  • Sector
  • TNGX Health Care
  • OBT Finance
  • Exchange
  • TNGX Nasdaq
  • OBT Nasdaq
  • Market Cap
  • TNGX 317.4M
  • OBT 267.9M
  • IPO Year
  • TNGX N/A
  • OBT N/A
  • Fundamental
  • Price
  • TNGX $1.28
  • OBT $23.91
  • Analyst Decision
  • TNGX Strong Buy
  • OBT Buy
  • Analyst Count
  • TNGX 7
  • OBT 1
  • Target Price
  • TNGX $12.33
  • OBT $35.50
  • AVG Volume (30 Days)
  • TNGX 789.6K
  • OBT 13.6K
  • Earning Date
  • TNGX 05-07-2025
  • OBT 04-30-2025
  • Dividend Yield
  • TNGX N/A
  • OBT 2.06%
  • EPS Growth
  • TNGX N/A
  • OBT N/A
  • EPS
  • TNGX N/A
  • OBT 2.47
  • Revenue
  • TNGX $42,069,000.00
  • OBT $100,028,000.00
  • Revenue This Year
  • TNGX N/A
  • OBT $13.29
  • Revenue Next Year
  • TNGX N/A
  • OBT $6.51
  • P/E Ratio
  • TNGX N/A
  • OBT $9.48
  • Revenue Growth
  • TNGX 15.17
  • OBT 6.48
  • 52 Week Low
  • TNGX $1.24
  • OBT $21.00
  • 52 Week High
  • TNGX $12.02
  • OBT $33.06
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 24.31
  • OBT 43.10
  • Support Level
  • TNGX $1.48
  • OBT $23.03
  • Resistance Level
  • TNGX $1.66
  • OBT $24.75
  • Average True Range (ATR)
  • TNGX 0.16
  • OBT 0.65
  • MACD
  • TNGX -0.02
  • OBT 0.03
  • Stochastic Oscillator
  • TNGX 5.00
  • OBT 36.97

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About OBT Orange County Bancorp Inc.

Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.

Share on Social Networks: